Skip to content
THE VELRI LIBRARY

Understand your health. Know what to ask.

Guides to treatments, lab results and common health questions. Sources are listed in every article.

All guides

201 guides · Page 5 of 17
Longevity & PerformanceLongevity

When repeat lab tests add useful information

A trend can help when the same measurement answers an ongoing question. More frequent testing is not automatically more informative.

2 sources · NIHRead · 2 min →
Longevity & PerformanceLongevity

NAD+ precursors and liver tests: start with the ingredient

Liver monitoring depends on the specific ingredient and clinical context. High-dose nicotinic acid risks should not be assigned to every NAD+ precursor.

4 sources · NIH, PubMed / PMCRead · 2 min →
Weight & Metabolic

Period changes during semaglutide treatment

A returning or changing period does not prove semaglutide has corrected a hormone problem. Cycle history and pregnancy possibility still matter.

3 sources · NIHRead · 2 min →
Hormones & Vitality

Progesterone during perimenopause: timing changes the meaning

Why progesterone results depend on cycle timing, ovulation and the reason for testing, rather than one universal target.

3 sources · The Menopause SocietyRead · 2 min →
Longevity & PerformanceLongevity

Glucose tests after travel: keep the timing in context

Sleep disruption, travel, and glucose testing can overlap. A fasting result, A1c, and cortisol test still answer different questions.

4 sources · NIHRead · 2 min →
Biomarkers & Labs

Albumin, creatinine and cystatin C: what each test measures

Understand blood albumin, urine albumin, creatinine and cystatin C, including why kidney tests are read together.

4 sources · NIHRead · 2 min →
Longevity & PerformanceLongevity

Are peptides safer because they are “natural”?

Natural origin does not establish a product’s safety. Ingredient, formulation, dose studied and individual risks matter.

4 sources · FDARead · 1 min →
Weight & Metabolic

Semaglutide and a higher resting heart rate

Resting heart rate can rise during semaglutide treatment. A wearable trend is useful context, but symptoms and clinical assessment matter.

1 source · NIHRead · 2 min →
Biomarkers & Labs

Fasting insulin vs. HbA1c: two different measurements

A1c reflects average blood glucose. Fasting insulin measures a hormone at one point in time. How the results fit together.

3 sources · NIHRead · 2 min →
Weight & Metabolic

A weight-loss plateau on tirzepatide: what to review

A plateau needs a treatment review, not a verdict about willpower. Start with the timeline, benefits, side effects, and recent changes.

3 sources · NIH, PubMed / PMCRead · 2 min →
Biomarkers & Labs

A lab panel and a preventive visit do different jobs

Blood tests contribute to a health review. They do not replace the history, examination, and screening decisions that make the review useful.

3 sources · FDARead · 2 min →
Hormones & Vitality

Mood changes and testosterone: why symptoms need more than one test

Irritability, low motivation and fatigue are not specific to testosterone deficiency. Symptoms and consistent results need to be assessed together.

3 sources · NIH, Endocrine SocietyRead · 2 min →